StimCell Energetics Inc. (STME)

Market Cap	5.87M -33.6%
Revenue (ttm)	n/a
Net Income	-935.22K
EPS	-0.05
Shares Out	20.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	67
Average Volume	9,101
Open	0.2860
Previous Close	0.2810
Day's Range	0.2860 - 0.2860
52-Week Range	0.1125 - 0.4800
Beta	50.61
RSI	40.40
Earnings Date	Apr 15, 2026

About StimCell Energetics

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for thr...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: STME